Literature DB >> 3340847

Epidemiology of HIV infection and AIDS in the United States.

J W Curran1, H W Jaffe, A M Hardy, W M Morgan, R M Selik, T J Dondero.   

Abstract

By the end of 1987, nearly 50,000 cases of acquired immunodeficiency syndrome (AIDS) had been reported since 1981, 20,745 in the past year alone. Black and Hispanic adults and children have reported rates 3 to 12 times as high as whites. This can be largely attributed to higher reported rates in black and Hispanic intravenous (IV) drug abusers, their sex partners, and infants. In 1986, reported AIDS deaths increased adult male and female mortality in the United States by an estimated 0.7 and 0.07%, respectively, with much greater increases in selected age groups or areas of the country. The greatest variation in infection with the human immunodeficiency virus (HIV) (0 to 70%) has been found in surveys of IV drug abusers, while surveys of homosexual men reveal infection rates of 20 to 50%. Infection with HIV ranged from 0 to 2.6% in limited sexually transmitted disease clinic surveys of heterosexual men and women without a history of IV drug abuse or known sexual contact with persons at increased risk. The modes of HIV transmission are now well understood, but a large amount of biologic variability in efficiency of transmission remains to be explained. The period between initial infection with HIV and the development of AIDS is variable, but the risk for disease progression increases with duration of infection.

Entities:  

Mesh:

Year:  1988        PMID: 3340847     DOI: 10.1126/science.3340847

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  79 in total

1.  A social learning model of adolescent contraceptive behavior.

Authors:  M L Balassone
Journal:  J Youth Adolesc       Date:  1991-12

2.  Geographic distribution of newborn HIV seroprevalence in relation to four sociodemographic variables.

Authors:  D L Morse; L Lessner; M G Medvesky; D M Glebatis; L F Novick
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

3.  National Health Interview Survey data on adult knowledge of AIDS in the United States.

Authors:  A M Hardy
Journal:  Public Health Rep       Date:  1990 Nov-Dec       Impact factor: 2.792

4.  To tell or not to tell: the ethical dilemmas of HIV test notification in epidemiologic research.

Authors:  A L Avins; B Lo
Journal:  Am J Public Health       Date:  1989-11       Impact factor: 9.308

5.  Prevalence of HIV infection in 646 heroin addicts and outcome of HIV-related conditions in the 266 followed up.

Authors:  C Mandelli; D Conte; R Barbera; T Masullo; S Pistoso; G P Aimo; L Cesarini; M Fraguelli; G P Lorini; P A Bianchi
Journal:  Eur J Epidemiol       Date:  1991-01       Impact factor: 8.082

6.  Global surveillance and forecasting of AIDS.

Authors:  J Chin; J Mann
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

7.  Early control of highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys usually results in long-lasting asymptomatic clinical outcomes.

Authors:  Tatsuhiko Igarashi; Yasuyuki Endo; Yoshiaki Nishimura; Charles Buckler; Reza Sadjadpour; Olivia K Donau; Marie-Jeanne Dumaurier; Ronald J Plishka; Alicia Buckler-White; Malcolm A Martin
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Alcohol use and contraception in first sexual experiences.

Authors:  B C Leigh; J Schafer; M T Temple
Journal:  J Behav Med       Date:  1995-02

9.  Improved Sensitivity of a Dual-Target HIV-1 Qualitative Test for Plasma and Dried Blood Spots.

Authors:  Stefanie P Templer; Britta Seiverth; Paul Baum; Wendy Stevens; Carole Seguin-Devaux; Sergio Carmona
Journal:  J Clin Microbiol       Date:  2016-05-18       Impact factor: 5.948

10.  Survival of human immunodeficiency virus (HIV), HIV-infected lymphocytes, and poliovirus in water.

Authors:  B E Moore
Journal:  Appl Environ Microbiol       Date:  1993-05       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.